Centessa IPO Presentation Deck
Committed Investors & Board Support
Backed by a broad array of healthcare-dedicated investors and fundamentally-driven mutual funds
medicxi
U.S.-based,
healthcare-focused fund
venrock
FRANKLIN TEMPLETON
INVESTMENTS
BOARD OF DIRECTORS
Francesco
De Rubertis
Board
Chairman;
Partner,
Medicxi
Saurabh
Saha
Chief Executive
Officer,
Centessa
Samarth
Kulkarni
CEO, CRISPR
Therapeutics
GENERAL
ATLANTIC
BOXER
CAPITAL
TAVISTOCK GROUP
WELLINGTON
MANAGEMENT®
LOGOS
CAPITAL
Mary Lynne
Hedley
Former
President &
COO, Tesaro
Brett
Zbar
Managing
Director,
General
Atlantic
VIDA
ventures
T.Rowe Price
BVF
PARTNERS LP
SAMSARA
BIOCAPITAL
Arjun
Goyal
Partner, Vida
Ventures
Robert
Califf
Janus Henderson
Former
Commissioner,
U.S. Food &
Drug Admin.
INVESTORS
CORMORANT ASSET MANAGEMENT
EcoR1
CAPITAL
LIFESCI
VENTURE PARTNERS
Carol
Stuckley
Former CFO,
Galderma
North America
Aaron
Kantoff
Venture
Partner,
Medicxi
CENTESSA
32View entire presentation